Literature DB >> 33858375

Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.

Hongjun Fei1, Songchang Chen1,2, Chenming Xu3,4.   

Abstract

BACKGROUND: Little data is available on prognostic biomarkers and effective treatment options for Kidney Renal Papillary Cell Carcinoma (KIRP) patients, to find potential prognostic biomarkers and new targets was an urgent mission for KIRP therapy.
METHODS: The differentially expressed autophagy-related genes (DEARGs) were screened out according to the RNA sequencing data in The Cancer Genome Atlas database, then identified survival-related DEARGs to establish a prognostic model for survival predicting of KIRP patients. Then we verified the robustness and validity of the prognostic risk model through clinicopathological data. At last, we evaluate the prognostic value of genes that formed the prognostic risk model individually.
RESULTS: We analyzed the expression of 232 autophagy-related genes (ARGs) in 289 KIRP and 32 non-tumor tissue cases, and 40 mRNAs were screened out as DEARGs. The functional and pathway enrichment analysis was done and protein-protein interaction network was constructed for all DEARGs. To sift candidate DEARGs associated with KIRP patients' survival and create an autophagy-related risk prognostic model, univariate and multivariate Cox regression analysis were did separately. Eventually 3 desirable independent prognostic DEARGs (P4HB, NRG1, and BIRC5) were picked out and used for construct the autophagy-related risk model. The accuracy of the prognostic risk model for survival prediction was assessed by Kaplan-Meier plotter, receiver-operator characteristic curve, and clinicopathological correlational analyses. The prognostic value of above 3 genes was verified individually by survival analysis and expression analysis on mRNA and protein level.
CONCLUSIONS: The autophagy-related prognostic model is accurate and applicable, it can predict OS independently for KIRP patients. Three independent prognostic DEARGs can benefit for facilitate personalized target treatment too.

Entities:  

Keywords:  Autophagy-related genes; Kidney renal papillary cell carcinoma; Prognostic risk signature; Survival prediction; Targeted therapy

Year:  2021        PMID: 33858375     DOI: 10.1186/s12885-021-08139-2

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  8 in total

Review 1.  Autophagy as a regulated pathway of cellular degradation.

Authors:  D J Klionsky; S D Emr
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

2.  Autophagy suppresses the proliferation of renal carcinoma cell.

Authors:  Z-L Wang; Q Deng; T Chong; Z-M Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-01       Impact factor: 3.507

Review 3.  Targeting cancer cells by synthetic lethality: autophagy and VHL in cancer therapeutics.

Authors:  Denise A Chan; Amato J Giaccia
Journal:  Cell Cycle       Date:  2008-10-12       Impact factor: 4.534

4.  A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy.

Authors:  Sandra Turcotte; Denise A Chan; Patrick D Sutphin; Michael P Hay; William A Denny; Amato J Giaccia
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

Review 5.  Molecular basis for sunitinib efficacy and future clinical development.

Authors:  Sandrine Faivre; George Demetri; William Sargent; Eric Raymond
Journal:  Nat Rev Drug Discov       Date:  2007-09       Impact factor: 84.694

6.  History of urinary tract infection and risk of renal cell carcinoma.

Authors:  Alexander S Parker; James R Cerhan; Charles F Lynch; Bradley C Leibovich; Kenneth P Cantor
Journal:  Am J Epidemiol       Date:  2004-01-01       Impact factor: 4.897

7.  Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.

Authors:  Hongyan Li; Xuefei Jin; Zhuo Zhang; Yuanyuan Xing; Xiangbo Kong
Journal:  Cell Biochem Funct       Date:  2012-10-22       Impact factor: 3.685

Review 8.  A Review of Papillary Renal Cell Carcinoma and MET Inhibitors.

Authors:  Katherine Emilie Rhoades Smith; Mehmet Asim Bilen
Journal:  Kidney Cancer       Date:  2019-11-01
  8 in total
  1 in total

1.  A Novel Autophagy-Related Prognostic Risk Model and a Nomogram for Survival Prediction of Oral Cancer Patients.

Authors:  Hongjun Fei; Xiongming Chen
Journal:  Biomed Res Int       Date:  2022-01-06       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.